ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
International Metals Mining Corp

International Metals Mining Corp (IMM)

0,08
0,00
(0,00%)
Geschlossen 14 Dezember 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,08
Gebot
0,07
Fragen
0,095
Volumen
-
0,00 Tagesbereich 0,00
0,02 52-Wochen-Bereich 0,135
Marktkapitalisierung
Handelsende
0,08
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
22.063
Ausgegebene Aktien
28.127.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,10
Gewinn pro Aktie (EPS)
-0,19
Erlöse
-
Nettogewinn
-5,4M

Über International Metals Mining Corp

Sektor
Miscellaneous Metal Ores,nec
Branche
Miscellaneous Metal Ores,nec
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
International Metals Mining Corp is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker IMM. The last closing price for International Metals Min... was $0,08. Over the last year, International Metals Min... shares have traded in a share price range of $ 0,02 to $ 0,135.

International Metals Min... currently has 28.127.000 shares in issue. The market capitalisation of International Metals Min... is $2,25 million. International Metals Min... has a price to earnings ratio (PE ratio) of -0.10.

IMM Neueste Nachrichten

Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal®

Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal® PR Newswire MONTREAL, July 26, 2011 MONTREAL, July 26, 2011 /PRNewswire/ - Immunotec Inc. (TSXV:...

Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease

Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease PR Newswire MONTREAL, June 14, 2011 MONTREAL, June 14, 2011 /PRNewswire/ - Immunotec Inc. (TSXV: IMM...

Immtech to be Listed on OTC Market

NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading its common stock on the Pink OTC Markets quotation...

Immtech to Reorganize Research and Development Operations

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its R&D operations. This restructuring will direct...

Immtech Announces Investment in China

NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in Gold Avenue Ltd., a privately-held Hong Kong company...

Immtech Receives Listing Determination Letter

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company received notice from the NYSE Amex LLC (the...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming...

Immtech To Reschedule Quarterly Conference Call

NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM) announced today that the Company will postpone the quarterly update conference call scheduled...

Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm

NEW YORK, Jan. 20 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has appointed Virchow, Krause & Company, LLP as its...

Immtech Announces Sale of Property Subsidiary in China

NEW YORK, Jan. 16 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has entered into an agreement to sell Immtech Life Science...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0114.28571428570.070.080.0769250.08CS
40.0552200.0250.10.02588010.06787787CS
120.05166.6666666670.030.10.02220630.03270076CS
260.045128.5714285710.0350.10.02163290.03153278CS
52-0.01-11.11111111110.090.1350.02191100.05567769CS
156-0.02-200.10.3550.02238110.14251192CS
260-0.02-200.10.3550.02238110.14251192CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ARCARCpoint Inc
$ 0,085
(112,50%)
105,12k
ETUE2gold Inc
$ 0,01
(100,00%)
665,3k
DMDataMetrex AI Limited
$ 0,01
(100,00%)
250k
QURIQuri Mayu Developments Ltd
$ 0,03
(100,00%)
5k
KGL.HKGL Resources Ltd
$ 0,05
(100,00%)
152,5k
AUGCAU Gold Corp
$ 0,005
(-50,00%)
750,69k
NORRNorrland Gold Corp
$ 0,025
(-44,44%)
228,01k
WWA.PWhitewater Acquisition Corp
$ 0,27
(-41,30%)
500
CBLTCBLT Inc
$ 0,015
(-40,00%)
95,5k
RCTRochester Resources Ltd
$ 0,015
(-40,00%)
1,96k
QNCQuantum Emotion Corp
$ 0,365
(35,19%)
7,8M
AMTAmeritrust Financial Technologies Inc
$ 0,105
(0,00%)
5,98M
VXTRVoxtur Analytics Corp
$ 0,05
(-9,09%)
5,89M
MATEBlockmate Ventures Inc
$ 0,155
(34,78%)
5,19M
KLXCarbon Done Right Developments Inc
$ 0,01
(0,00%)
4,28M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock